Related Experiment Video
Updated: Jun 15, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Genetic Markers as Predictors of Prognosis and Treatment Response in Patients with Oral Cancer: A Prospective Study
P Rishal Mohammed1, Mitali Dash2, Seema Pati3
1College of Dental Medicine, Qatar University, Doha, Qatar.
Introduction:
"Oral squamous cell carcinoma (OSCC)" is a prevalent malignancy globally, with significant morbidity and mortality. Genetic markers are emerging as vital tools in predicting prognosis and treatment responses. This research explores genetic markers' role in OSCC prognosis and therapeutic outcomes.
Methods:
This prospective research analyzed 150 OSCC patients, investigating the prognostic value of three genetic markers: TP53 mutations, miR-31 expression, and "mismatch repair (MMR)" protein loss.
Results:
Patients with TP53 mutations exhibited lower survival rates (P < 0.05). Elevated miR-31 was associated with aggressive disease (P < 0.01), while MMR loss correlated with advanced tumor stages (P < 0.001).
Conclusion:
Genetic markers, like TP53 mutations, miR-31, and MMR loss, can effectively predict prognosis and treatment responses in OSCC. Integrating these markers into clinical practice can enhance personalized treatment strategies.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Related Concept Videos
Cancer Survival Analysis
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
There are several types of targeted therapies against...